ATE316979T1 - Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt - Google Patents

Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt

Info

Publication number
ATE316979T1
ATE316979T1 AT97928617T AT97928617T ATE316979T1 AT E316979 T1 ATE316979 T1 AT E316979T1 AT 97928617 T AT97928617 T AT 97928617T AT 97928617 T AT97928617 T AT 97928617T AT E316979 T1 ATE316979 T1 AT E316979T1
Authority
AT
Austria
Prior art keywords
protein
coagulase
binding protein
staphylococus
negative
Prior art date
Application number
AT97928617T
Other languages
English (en)
Inventor
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan-Ingmar Flock
Martin Lindberg
Original Assignee
Biostapro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostapro Ab filed Critical Biostapro Ab
Application granted granted Critical
Publication of ATE316979T1 publication Critical patent/ATE316979T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97928617T 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt ATE316979T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Publications (1)

Publication Number Publication Date
ATE316979T1 true ATE316979T1 (de) 2006-02-15

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928617T ATE316979T1 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt

Country Status (10)

Country Link
US (2) US6733758B1 (de)
EP (1) EP0922056B1 (de)
JP (1) JP4173549B2 (de)
AT (1) ATE316979T1 (de)
AU (1) AU3282597A (de)
CA (1) CA2294433A1 (de)
DE (1) DE69735207T2 (de)
ES (1) ES2258280T3 (de)
SE (1) SE9602496D0 (de)
WO (1) WO1997048727A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
CA2310217A1 (en) * 1997-11-26 1999-06-03 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
WO2000012132A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
ES2322409T3 (es) * 1998-08-31 2009-06-19 Inhibitex, Inc. Vacunas multicomponentes contra staphylococcus aureus.
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
KR100871330B1 (ko) * 1998-08-31 2008-12-01 더 프로보스트 펠로우스 앤드 스콜라스 오브 더 칼리지 오브 더 홀리 앤드 언디바이디드 트리니티 오브 퀸 엘리자베스 니어 더블린 응고효소 음성 포도상구균 유래의 폴리펩타이드 및폴리뉴클레오타이드
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
CN100359327C (zh) 2001-06-15 2008-01-02 英希比泰克斯公司 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体
WO2003076470A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
AU2004220590B2 (en) 2003-03-07 2010-02-18 Inhibitex, Inc. Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EP2305294B1 (de) 2004-09-22 2015-04-01 GlaxoSmithKline Biologicals SA Immunogene Zusammensetzung zur Verwendung zur Impfung gegen Staphylokokken
EP2476434A1 (de) 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogene Zusammensetzung
EP2010276B1 (de) * 2006-04-26 2014-01-22 Covidien LP Mehrfachmodus-mikroporationsvorrichtung
WO2010151544A1 (en) 2009-06-22 2010-12-29 Wyeth Llc Immunogenic compositions of staphylococcus aureus antigens
CN102666583B (zh) 2009-07-15 2015-11-25 Aimm医疗股份公司 革兰氏阳性细菌特异性结合化合物
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181578B1 (de) 1984-11-06 1991-09-04 Dr. Karl Thomae GmbH Antibiotisches Polypeptid, Verfahren zu seiner Herstellung und seine Verwendung
DE58905744D1 (de) * 1988-07-15 1993-11-04 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
AU4837193A (en) * 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
EP0922056B1 (de) 2006-02-01
DE69735207T2 (de) 2006-11-02
US20040209326A1 (en) 2004-10-21
WO1997048727A1 (en) 1997-12-24
US7160990B2 (en) 2007-01-09
CA2294433A1 (en) 1997-12-24
DE69735207D1 (de) 2006-04-13
AU3282597A (en) 1998-01-07
JP4173549B2 (ja) 2008-10-29
SE9602496D0 (sv) 1996-06-20
US6733758B1 (en) 2004-05-11
EP0922056A1 (de) 1999-06-16
ES2258280T3 (es) 2006-08-16
JP2001503609A (ja) 2001-03-21

Similar Documents

Publication Publication Date Title
ATE316979T1 (de) Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
DK0713529T3 (da) Vækst-/differentieringsfaktor af TGF-beta-familien
DE69228701T2 (de) Fragmente von Prion Proteinen.
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
DE69933998D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DE59309458D1 (de) Synthetische Peptide, Antikörper dagegen und ihre Verwendung
DE69131580D1 (de) GDF-1 und UOG1 Proteine
MXPA02008239A (es) Gen humano de la esquizofrenia.
DE69535855D1 (de) Calciumbindende rekombinante antikörper gegen protein c
ES2072868T3 (es) Proteina capaz de unir la fibronectina y su preparacion.
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
EP0990703A4 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
NO922421L (no) Collagenbindende protein, samt fremstilling derav
AU4136797A (en) Novel semaphorin gene: semaphorin y
DE69534596D1 (de) Epil/plazentin
CY1110308T1 (el) Μοριο νουκλεϊνικου οξεος, το οποιο περιλαμβανει μια κωδικευσουσα για αιμοκυανινη ακολουθια νουκλεϊνικου οξεος και τουλαχιστον μια ακολουθια ιντρονιου
CA2235471A1 (en) Dna encoding a plasminogen activating protein
ATE351909T1 (de) Neue peptidfragmente zur reinigung von proteinen
SE0003573D0 (sv) Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
SE9604439D0 (sv) New receptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties